Assignee
EMMELLEN BIOTECH PHARMACEUTICA
IN·1 granted patent·2 pending applications·0 citations·filing 2004–2008
Top patents by PatentIndex Score
3 records- 0132US7414153B2Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanolEMMELLEN BIOTECH PHARMACEUTICA·Filed 2005·Granted Aug 19, 2008·0 cites·15 claims
- 0225US2009112025A1Catalytic hydrogenation process and novel catalyst for itEMMELLEN BIOTECH PHARMACEUTICA·Filed 2008·Application pending·0 cites
- 0316US2008293971A1A Process for the Preparation of R-(-)-N, Alpha-Dimethylphenethylamine (Levmethamfetamine) or S-(+)-N, Alpha-Dimethylphenethylamine (Methamphetamine) from D-Ephendrine, or L-Ephedrine RespectivelyEMMELLEN BIOTECH PHARMACEUTICA·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMMELLEN BIOTECH PHARMACEUTICA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →